These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 9892993

  • 21. Pharmacokinetics and dosimetry of iodine-125-IUdR in the treatment of colorectal cancer metastatic to liver.
    Daghighian F, Humm JL, Macapinlac HA, Zhang J, Izzo J, Finn R, Kemeny N, Larson SM.
    J Nucl Med; 1996 Apr; 37(4 Suppl):29S-32S. PubMed ID: 8676201
    [Abstract] [Full Text] [Related]

  • 22. Selective uptake of toxic nucleoside (125IUdR) by resistant cancer.
    Bagshawe KD, Sharma K, Southall PJ, Boden JA, Boxer GM, Patridge TA, Antoniw P, Pedley RB.
    Br J Radiol; 1991 Jan; 64(757):37-44. PubMed ID: 1998836
    [Abstract] [Full Text] [Related]

  • 23. Cytotoxicity of alpha-particle-emitting 5-[211At]astato-2'-deoxyuridine in human cancer cells.
    Larsen RH, Vaidyanathan G, Zalutsky MR.
    Int J Radiat Biol; 1997 Jul; 72(1):79-90. PubMed ID: 9246197
    [Abstract] [Full Text] [Related]

  • 24. Synthetic, implantable polymers for IUdR radiosensitization of experimental human malignant glioma.
    Yuan X, Dillehay LE, Williams JR, Williams JA.
    Cancer Biother Radiopharm; 1999 Jun; 14(3):187-202. PubMed ID: 10850303
    [Abstract] [Full Text] [Related]

  • 25. Residualizing iodine markedly improved tumor targeting using bispecific antibody-based pretargeting.
    van Schaijk FG, Broekema M, Oosterwijk E, van Eerd JE, McBride BJ, Goldenberg DM, Corstens FH, Boerman OC.
    J Nucl Med; 2005 Jun; 46(6):1016-22. PubMed ID: 15937314
    [Abstract] [Full Text] [Related]

  • 26. Unlabelled iododeoxyuridine increases the cytotoxicity and incorporation of [1251]-iododeoxyuridine in two human glioblastoma cell lines.
    Xiao WH, Dupertuis YM, Mermillod B, Sun LQ, de Tribolet N, Buchegger F.
    Nucl Med Commun; 2000 Oct; 21(10):947-53. PubMed ID: 11130336
    [Abstract] [Full Text] [Related]

  • 27. 124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice.
    Sundaresan G, Yazaki PJ, Shively JE, Finn RD, Larson SM, Raubitschek AA, Williams LE, Chatziioannou AF, Gambhir SS, Wu AM.
    J Nucl Med; 2003 Dec; 44(12):1962-9. PubMed ID: 14660722
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. 5-[123I]iodo-2'-deoxyuridine in the radiotherapy of an early ascites tumor model.
    Baranowska-Kortylewicz J, Makrigiorgos GM, Van den Abbeele AD, Berman RM, Adelstein SJ, Kassis AI.
    Int J Radiat Oncol Biol Phys; 1991 Nov; 21(6):1541-51. PubMed ID: 1938564
    [Abstract] [Full Text] [Related]

  • 32. Biodistribution studies on L-3-[fluorine-18]fluoro-alpha-methyl tyrosine: a potential tumor-detecting agent.
    Inoue T, Tomiyoshi K, Higuichi T, Ahmed K, Sarwar M, Aoyagi K, Amano S, Alyafei S, Zhang H, Endo K.
    J Nucl Med; 1998 Apr; 39(4):663-7. PubMed ID: 9544678
    [Abstract] [Full Text] [Related]

  • 33. Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin.
    Koppe MJ, Bleichrodt RP, Soede AC, Verhofstad AA, Goldenberg DM, Oyen WJ, Boerman OC.
    J Nucl Med; 2004 Jul; 45(7):1224-32. PubMed ID: 15235070
    [Abstract] [Full Text] [Related]

  • 34. Study on biodistribution and imaging of radioiodinated arginine-arginine-leucine peptide in nude mice bearing human prostate carcinoma.
    Yu M, Zhou H, Liu X, Huo Y, Zhu Y, Chen Y.
    Ann Nucl Med; 2010 Jan; 24(1):13-9. PubMed ID: 19997991
    [Abstract] [Full Text] [Related]

  • 35. Differential cytotoxicity of [123I]IUdR, [125I]IUdR and [131I]IUdR to human glioma cells in monolayer or spheroid culture: effect of proliferative heterogeneity and radiation cross-fire.
    Neshasteh-Riz A, Mairs RJ, Angerson WJ, Stanton PD, Reeves JR, Rampling R, Owens J, Wheldon TE.
    Br J Cancer; 1998 Jan; 77(3):385-90. PubMed ID: 9472632
    [Abstract] [Full Text] [Related]

  • 36. PET imaging drug distribution after intratumoral injection: the case for (124)I-iododeoxyuridine in malignant gliomas.
    Roelcke U, Hausmann O, Merlo A, Missimer J, Maguire RP, Freitag P, Radü EW, Weinreich R, Gratzl O, Leenders KL.
    J Nucl Med; 2002 Nov; 43(11):1444-51. PubMed ID: 12411546
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Biodistribution and pharmacokinetics of 125I-labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma.
    Chrastina A, Závada J, Parkkila S, Kaluz S, Kaluzová M, Rajcáni J, Pastorek J, Pastoreková S.
    Int J Cancer; 2003 Jul 20; 105(6):873-81. PubMed ID: 12767076
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.